-
Google-parent Alphabet beats expectations, cloud revenue nearly doubles
-
Wildfires ravage parts of southern France, Italy and Spain
-
US announces civilian nuclear deal with Saudi Arabia
-
Alphabet beats expectations in second quarter, cloud revenue nearly doubles
-
Tesla shares dip after profit misses expectations
-
Trump threatens Iran infrastructure, Tehran vows 'eye for eye'
-
Red Sox tie club record with 15th straight MLB win
-
US teen withdraws lawsuit against Meta over social media addiction
-
US eyes offshore nuclear reactors
-
Lebanon PM says Beirut working for 'complete Israeli withdrawal'
-
The Sterling Announces Luxury Cocktail Lounge Concept and Investor Showcase in Orlando
-
EU conditionally clears Paramount bid for Warner Bros.
-
Inter Miami signs Brazil veteran Casemiro but MLS probes deal
-
Philipsen snaps 'horrible' drought with Tour de France stage 17 victory
-
White House accuses China's Moonshot of stealing Anthropic AI
-
US trial of Venezuela's Maduro set for June 2027
-
Pogacar sweating on Yates's fitness ahead of Tour Queen stage
-
New UK PM Burnham gets early boost as inflation dips
-
Ukrainian soldiers and civilians welcome new army commander
-
Samsung launches new, more expensive foldable smartphones
-
UK fintech Revolut valuation soars to $115 bn: source
-
Philipsen ends 'horrible' drought with Tour de France 17th stage victory
-
German FM, on Africa tour, eyes business ties amid US, China pressure
-
Hungary's Orban says graft case is 'pretext' to target his party
-
Rubio says at ASEAN meeting he expects 'positive' US visit by China's Xi
-
South African tycoon Motsepe rules out presidential bid
-
Philipsen wins Tour de France 17th stage
-
Trump threatens Iran bridges, power as payback for Hormuz attacks
-
DonnaPro Introduces AI-Trained Executive Assistants for European CEOs
-
Germany's Merz replaces leader ousted over surrogacy row
-
Happy birthday, George! UK prince becomes a teenager
-
CAF chief Motsepe backs Infantino despite criticism
-
Oil prices jump on Mideast war, stock markets diverge
-
Evacuees from Spain's wildfire struggle with scale of devastation
-
US hits Iranian island, says war cost at $37.5 bn
-
Ancient Lebanese city of Tyre added to heritage danger list
-
Metal mining's carbon footprint far larger than thought: study
-
Extreme heatwave grips Tunisia as wide power cuts fuel frustration
-
TokenInsight Q2 2026 Report: TradFi Momentum Lifts MEXC to No. 2 in Commodity Perpetuals
-
'Beautiful game' provides Venezuelans with welcome distraction in wake of tragedy
-
Leonardo chief sees potential for Germany to join GCAP fighter jet project
-
Oil prices surge on Mideast war, stock markets diverge
-
Louvre heist gallery reopens to public, but with nothing to steal
-
Fury says 'best yet to come' ahead of Thailand fight
-
Ukraine's new army chief: who is Mykhailo Drapaty?
-
Japan suffers heat 'disaster as cities hit by 'cruelly hot' days
-
India student protests keep up pressure on Modi government
-
In Kazakhstan, emptying villages and overcrowded cities
-
Italian FA chief says in touch with Guardiola over coaching vacancy
-
Hitler's Austrian birthplace transformed into police station
Medicine Nobel to trio who identified immune system's 'security guards'
A US-Japanese trio on Monday won the Nobel Prize in Medicine for research into how the immune system is kept in check by identifying its "security guards", the Nobel jury said.
The discoveries by Mary E. Brunkow and Fred Ramsdell of the United States and Japan's Shimon Sakaguchi have been decisive for understanding how the immune system functions and why we do not all develop serious autoimmune diseases.
Sakaguchi, a professor at the Immunology Frontier Research Centre in Osaka, told Swedish broadcaster Sveriges Radio: "It's an honour for me. I'm looking forward to visiting Stockholm in December" to receive the award in person.
The Nobel committee was however unable to reach the two US-based laureates to break the news to them in person.
"If you hear this, call me," the head of the Nobel Assembly, Thomas Perlmann, joked at the press conference announcing the winners.
The three won the prize for research that identified the immune system's "security guards", called regulatory T-cells.
Their work concerns "peripheral immune tolerance" that prevents the immune system from harming the body, and has led to a new field of research and the development of potential medical treatments now being evaluated in clinical trials.
"The hope is to be able to treat or cure autoimmune diseases, provide more effective cancer treatments and prevent serious complications after stem cell transplants," the jury said.
- Protecting the body -
Sakaguchi made the first key discovery in 1995.
At the time, many researchers were convinced that immune tolerance only developed due to potentially harmful immune cells being eliminated in the thymus, through a process called "central tolerance".
Sakaguchi, 74, showed that the immune system is more complex and discovered a previously unknown class of immune cells, which protect the body from autoimmune diseases.
Brunkow, born in 1961 and a senior project manager at the Institute for Systems Biology in Seattle, and Ramsdell, a 64-year-old senior advisor at Sonoma Biotherapeutics in San Francisco, made the other key discovery in 2001, when they were able to explain why certain mice were particularly vulnerable to autoimmune diseases.
"They had discovered that mice have a mutation in a gene that they named Foxp3," the jury said.
"They also showed that mutations in the human equivalent of this gene cause a serious autoimmune disease, IPEX."
Two years later, Sakaguchi was able to link these discoveries.
The trio will receive their prize -- a diploma, a gold medal and $1.2 million split three ways -- at a formal ceremony in Stockholm on December 10.
Researchers from major US institutions typically dominate the Nobel science prizes, due largely to the US' longstanding investment in basic science and academic freedoms.
But that could change down the line following massive US budget cuts to science programmes announced by President Donald Trump.
Since January, the US National Institutes of Health (NIH) has terminated 2,100 research grants totalling around $9.5 billion and $2.6 billion in contracts, according to an independent database called Grant Watch.
- Trump eyeing Peace Prize -
Thomas Perlmann, secretary general of the committee that awards the Nobel Prize for Medicine, told AFP it was "no coincidence that the US has by far the most Nobel laureates".
"But there is now a creeping sense of uncertainty about the US' willingness to maintain their leading position in research," he said.
Trump has meanwhile made no secret of the fact that he wants to win a Nobel himself -- the Peace Prize.
Nobel experts have however said his "America First" policies and divisive style give him little chance.
"It's completely unthinkable," Oeivind Stenersen, a historian who has conducted research and co-written a book on the prize, told AFP.
"(Trump) is in many ways the opposite of the ideals that the Nobel Prize represents," he said, citing "multilateral cooperation" as an example.
Trump "follows his own path, unilaterally," Stenersen added.
Sudan's networks of volunteers Emergency Response Rooms (ERR) helping people survive war and famine -- are seen as a possible contender this year, as are media watchdogs the Committee to Protect Journalists, Reporters Without Borders, and Yulia Navalnaya, the widow of Kremlin critic Alexei Navalny.
K.Sutter--VB